Section Chief, Transfusion Medicine; CLIA Medical Director, Clinical Laboratories, Ronald Reagan UCLA Medical Center
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA
Los Angeles, California
Disclosure information not submitted.
AM26-MO-21-L - AABB/THOR - Debate on the Optimal Product for Fibrinogen Replacement
Monday, October 19, 2026
2:00 PM - 3:00 PM EST